• 9238 Citations
  • 42 h-Index
1987 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Sandro Pignata is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Carboplatin Medicine & Life Sciences
Platinum Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
trabectedin Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1987 2019

A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups

Macchia, G., Lazzari, R., Colombo, N., Laliscia, C., Capelli, G., D'Agostino, G. R., Deodato, F., Maranzano, E., Ippolito, E., Ronchi, S., Paiar, F., Scorsetti, M., Cilla, S., Ingargiola, R., Huscher, A., Cerrotta, A. M., Fodor, A., Vicenzi, L., Russo, D., Borghesi, S. & 8 others, Perrucci, E., Pignata, S., Aristei, C., Morganti, A. G., Scambia, G., Valentini, V., Jereczek-Fossa, B. A. & Ferrandina, G., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Radiosurgery
Ovarian Neoplasms
Multicenter Studies
Retrospective Studies
Safety
5 Citations (Scopus)

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

Matulonis, U. A., Shapira-Frommer, R., Santin, A. D., Lisyanskaya, A. S., Pignata, S., Vergote, I., Raspagliesi, F., Sonke, G. S., Birrer, M., Provencher, D. M., Sehouli, J., Colombo, N., González-Martín, A., Oaknin, A., Ottevanger, P. B., Rudaitis, V., Katchar, K., Wu, H., Keefe, S., Ruman, J. & 1 others, Ledermann, J. A., Jul 1 2019, In : Annals of Oncology. 30, 7, p. 1080-1087 8 p., mdz135.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Safety
Platinum
Disease-Free Survival
Biomarkers

Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M. T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., Sabbatini, R., Conte, C., Cecere, S. C., Maltese, G. & Scambia, G., Jan 1 2019, (Accepted/In press) In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Carboplatin
Endometrial Neoplasms
Paclitaxel
Disease-Free Survival
Combination Drug Therapy

Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study

Bergamini, A., Cormio, G., Ferrandina, G., Lorusso, D., Giorda, G., Scarfone, G., Bocciolone, L., Raspagliesi, F., Tateo, S., Cassani, C., Savarese, A., Breda, E., De Giorgi, U., Mascilini, F., Candiani, M., Kardhashi, A., Biglia, N., Perrone, A. M., Pignata, S. & Mangili, G., Aug 2019, In : Gynecologic Oncology. 154, 2, p. 323-327 5 p.

Research output: Contribution to journalArticle

Ovariectomy
Cystectomy
Fertility
Granulosa cell tumor of the ovary
Survival